The Mayo Clinic notes that even at therapeutic mega-doses, side effects are uncommon and mild: headache, nausea, diarrhea, fatigue, and a tingling sensation in extremities
Current GLP-1 therapies (Ozempic/semaglutide, dulaglutide, liraglutide) require: Refrigeration and cold-chain storage Subcutaneous injections (compliance issues) Complex, expensive manufacturing Restrictive dosing (oral semaglutide: overnight fasting, 30-min wait before eating) All prior candidates failed due to poor potency or inadequate pharmacokinetics ( 3,100 adults with obesity (without diabetes)
Patients with kidney disease, Leber's disease, megaloblastic anemia, and breastfeeding women should discuss the benefits and risks and dosage with their doctor
With a vitamin B12 deficiency comes the risk of suffering from megaloblastic anemia, including symptoms of fatigue, weakness, pale skin, lack of appetite, infertility, and unexplained weight loss
Injection Technique Same-Day, Separate-Site The most-described community pattern for two-compound stacks is same-day, separate-site injection: both compounds delivered the same day each week, but at different subcutaneous sites
Gut Microbes